Cargando…
Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery
Electrospun nanofibers are gaining interest as ocular drug delivery platforms that may adapt to the eye surface and provide sustained release. The aim of this work was to design an innovative ophthalmic insert composed of hyaluronan (HA) nanofibers for the dual delivery of an antioxidant (ferulic ac...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151120/ https://www.ncbi.nlm.nih.gov/pubmed/32192007 http://dx.doi.org/10.3390/pharmaceutics12030274 |
_version_ | 1783521176934416384 |
---|---|
author | Grimaudo, Maria Aurora Concheiro, Angel Alvarez-Lorenzo, Carmen |
author_facet | Grimaudo, Maria Aurora Concheiro, Angel Alvarez-Lorenzo, Carmen |
author_sort | Grimaudo, Maria Aurora |
collection | PubMed |
description | Electrospun nanofibers are gaining interest as ocular drug delivery platforms that may adapt to the eye surface and provide sustained release. The aim of this work was to design an innovative ophthalmic insert composed of hyaluronan (HA) nanofibers for the dual delivery of an antioxidant (ferulic acid, FA) and an antimicrobial peptide (ε-polylysine, ε-PL). Polyvinylpyrrolidone (PVP) was added to facilitate the electrospinning process. Fibers with diameters of approx. 100 nm were obtained with PVP 5%-HA 0.8% w/v and PVP 10%-HA 0.5% w/v mixtures in ethanol:water 4:6 v/v. An increase in PVP concentration to 20% w/v in both presence and absence of HA rendered fibers of approx. 1 µm. PVP 5%-HA 0.8% w/v fibers were loaded with 83.3 ± 14.0 µg FA per mg. After nanofibers crosslinking with ε-PL, blank and FA-loaded inserts showed a mean thickness of 270 ± 21 µm and 273 ± 41 µm, respectively. Blank and FA-loaded inserts completely released ε-PL within 30 min under sink conditions, whereas FA-loaded inserts released the antioxidant within 20 min. Both blank and FA-loaded inserts were challenged against Pseudomonas aeruginosa and Staphylococcus aureus, demonstrating their efficacy against relevant microbial species. |
format | Online Article Text |
id | pubmed-7151120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71511202020-04-20 Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery Grimaudo, Maria Aurora Concheiro, Angel Alvarez-Lorenzo, Carmen Pharmaceutics Article Electrospun nanofibers are gaining interest as ocular drug delivery platforms that may adapt to the eye surface and provide sustained release. The aim of this work was to design an innovative ophthalmic insert composed of hyaluronan (HA) nanofibers for the dual delivery of an antioxidant (ferulic acid, FA) and an antimicrobial peptide (ε-polylysine, ε-PL). Polyvinylpyrrolidone (PVP) was added to facilitate the electrospinning process. Fibers with diameters of approx. 100 nm were obtained with PVP 5%-HA 0.8% w/v and PVP 10%-HA 0.5% w/v mixtures in ethanol:water 4:6 v/v. An increase in PVP concentration to 20% w/v in both presence and absence of HA rendered fibers of approx. 1 µm. PVP 5%-HA 0.8% w/v fibers were loaded with 83.3 ± 14.0 µg FA per mg. After nanofibers crosslinking with ε-PL, blank and FA-loaded inserts showed a mean thickness of 270 ± 21 µm and 273 ± 41 µm, respectively. Blank and FA-loaded inserts completely released ε-PL within 30 min under sink conditions, whereas FA-loaded inserts released the antioxidant within 20 min. Both blank and FA-loaded inserts were challenged against Pseudomonas aeruginosa and Staphylococcus aureus, demonstrating their efficacy against relevant microbial species. MDPI 2020-03-17 /pmc/articles/PMC7151120/ /pubmed/32192007 http://dx.doi.org/10.3390/pharmaceutics12030274 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Grimaudo, Maria Aurora Concheiro, Angel Alvarez-Lorenzo, Carmen Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery |
title | Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery |
title_full | Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery |
title_fullStr | Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery |
title_full_unstemmed | Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery |
title_short | Crosslinked Hyaluronan Electrospun Nanofibers for Ferulic Acid Ocular Delivery |
title_sort | crosslinked hyaluronan electrospun nanofibers for ferulic acid ocular delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151120/ https://www.ncbi.nlm.nih.gov/pubmed/32192007 http://dx.doi.org/10.3390/pharmaceutics12030274 |
work_keys_str_mv | AT grimaudomariaaurora crosslinkedhyaluronanelectrospunnanofibersforferulicacidoculardelivery AT concheiroangel crosslinkedhyaluronanelectrospunnanofibersforferulicacidoculardelivery AT alvarezlorenzocarmen crosslinkedhyaluronanelectrospunnanofibersforferulicacidoculardelivery |